Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Australian ChemGenex Readies Omapro For Second NDA Despite U.S. FDA Setbacks

May 06 2010

• By PharmAsia News

Related Content

U.S. FDA Says Australian ChemGenex Needs Companion Diagnostic For Omapro

Mar 24 2010

Australian ChemGenex's Omapro Faces Scaled Back Efficacy Claims After Trial Shortcomings

Feb 10 2010

No Additional Omapro Trials Needed, U.S. FDA Tells Australian ChemGenex In Complete Response Letter

Apr 12 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window